Urinary iodine is increased in papillary thyroid carcinoma but is not altered by regional population iodine intake status

A meta-analysis and implications

Ann-Rong Yan, Xiaojuan Zhang, Hong Shen, Xia Zhou, Rui Li, Zhexing Yuan

Research output: Contribution to journalArticle

Abstract

Excessive iodine intake has been associated with increased risk of thyroid cancer (TC) in many studies, but the results have not been consistent. Since it was common knowledge that urinary iodine (UI) is considered a sensitive marker of current iodine intake, we conducted a meta-analysis to clarify the association between high UI and TC. We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, and the Cochrane Collaboration. Betweengroup meta-analyses were performed to compare UI between TC patients and the healthy/euthyroid subjects in local residents and benign thyroid nodules (BTN) patients. Then, between-group meta-analyses to compare the incidence rate of iodine excess were also conducted. The 22 case-control studies included in the meta-analyses represented 15,476 participants. It is the first time to clarify that UI was increased in PTC patients, but was not altered by regional population iodine intake status. Compared with BTN patients, PTC patients exhibited both higher UIC and higher odds ratio of iodine excess only in adequate iodine intake status subgroup; UIC, not the odds ratio of iodine excess, was higher in patients with PTC than those with BTN in above requirements iodine intake subgroup. A novel insight is offered that high UI in PTC patients was less influenced by regional population iodine intake status. It is indicted that high iodine intake is not a risk factor for PTC and high urinary iodine is just a specific characteristic of the disease.

Original languageEnglish
Pages (from-to)497-514
Number of pages18
JournalEndocrine Journal
Volume66
Issue number6
DOIs
Publication statusPublished - 2019

Fingerprint

Iodine
Meta-Analysis
Population
Factor IX
Thyroid Nodule
Thyroid Neoplasms
Papillary Thyroid cancer
Odds Ratio
Case-Control Studies
Healthy Volunteers

Cite this

Yan, Ann-Rong ; Zhang, Xiaojuan ; Shen, Hong ; Zhou, Xia ; Li, Rui ; Yuan, Zhexing. / Urinary iodine is increased in papillary thyroid carcinoma but is not altered by regional population iodine intake status : A meta-analysis and implications. In: Endocrine Journal. 2019 ; Vol. 66, No. 6. pp. 497-514.
@article{3091211834994e4381deef0b8e760fa8,
title = "Urinary iodine is increased in papillary thyroid carcinoma but is not altered by regional population iodine intake status: A meta-analysis and implications",
abstract = "Excessive iodine intake has been associated with increased risk of thyroid cancer (TC) in many studies, but the results have not been consistent. Since it was common knowledge that urinary iodine (UI) is considered a sensitive marker of current iodine intake, we conducted a meta-analysis to clarify the association between high UI and TC. We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, and the Cochrane Collaboration. Betweengroup meta-analyses were performed to compare UI between TC patients and the healthy/euthyroid subjects in local residents and benign thyroid nodules (BTN) patients. Then, between-group meta-analyses to compare the incidence rate of iodine excess were also conducted. The 22 case-control studies included in the meta-analyses represented 15,476 participants. It is the first time to clarify that UI was increased in PTC patients, but was not altered by regional population iodine intake status. Compared with BTN patients, PTC patients exhibited both higher UIC and higher odds ratio of iodine excess only in adequate iodine intake status subgroup; UIC, not the odds ratio of iodine excess, was higher in patients with PTC than those with BTN in above requirements iodine intake subgroup. A novel insight is offered that high UI in PTC patients was less influenced by regional population iodine intake status. It is indicted that high iodine intake is not a risk factor for PTC and high urinary iodine is just a specific characteristic of the disease.",
keywords = "A meta-analysis, Excessive iodine intake, Papillary thyroid carcinoma, Thyroid cancer, Urinary iodine",
author = "Ann-Rong Yan and Xiaojuan Zhang and Hong Shen and Xia Zhou and Rui Li and Zhexing Yuan",
year = "2019",
doi = "10.1507/endocrj.EJ18-0532",
language = "English",
volume = "66",
pages = "497--514",
journal = "Endocrinologia Japonica",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "6",

}

Urinary iodine is increased in papillary thyroid carcinoma but is not altered by regional population iodine intake status : A meta-analysis and implications. / Yan, Ann-Rong; Zhang, Xiaojuan; Shen, Hong; Zhou, Xia; Li, Rui; Yuan, Zhexing.

In: Endocrine Journal, Vol. 66, No. 6, 2019, p. 497-514.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Urinary iodine is increased in papillary thyroid carcinoma but is not altered by regional population iodine intake status

T2 - A meta-analysis and implications

AU - Yan, Ann-Rong

AU - Zhang, Xiaojuan

AU - Shen, Hong

AU - Zhou, Xia

AU - Li, Rui

AU - Yuan, Zhexing

PY - 2019

Y1 - 2019

N2 - Excessive iodine intake has been associated with increased risk of thyroid cancer (TC) in many studies, but the results have not been consistent. Since it was common knowledge that urinary iodine (UI) is considered a sensitive marker of current iodine intake, we conducted a meta-analysis to clarify the association between high UI and TC. We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, and the Cochrane Collaboration. Betweengroup meta-analyses were performed to compare UI between TC patients and the healthy/euthyroid subjects in local residents and benign thyroid nodules (BTN) patients. Then, between-group meta-analyses to compare the incidence rate of iodine excess were also conducted. The 22 case-control studies included in the meta-analyses represented 15,476 participants. It is the first time to clarify that UI was increased in PTC patients, but was not altered by regional population iodine intake status. Compared with BTN patients, PTC patients exhibited both higher UIC and higher odds ratio of iodine excess only in adequate iodine intake status subgroup; UIC, not the odds ratio of iodine excess, was higher in patients with PTC than those with BTN in above requirements iodine intake subgroup. A novel insight is offered that high UI in PTC patients was less influenced by regional population iodine intake status. It is indicted that high iodine intake is not a risk factor for PTC and high urinary iodine is just a specific characteristic of the disease.

AB - Excessive iodine intake has been associated with increased risk of thyroid cancer (TC) in many studies, but the results have not been consistent. Since it was common knowledge that urinary iodine (UI) is considered a sensitive marker of current iodine intake, we conducted a meta-analysis to clarify the association between high UI and TC. We adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, and the Cochrane Collaboration. Betweengroup meta-analyses were performed to compare UI between TC patients and the healthy/euthyroid subjects in local residents and benign thyroid nodules (BTN) patients. Then, between-group meta-analyses to compare the incidence rate of iodine excess were also conducted. The 22 case-control studies included in the meta-analyses represented 15,476 participants. It is the first time to clarify that UI was increased in PTC patients, but was not altered by regional population iodine intake status. Compared with BTN patients, PTC patients exhibited both higher UIC and higher odds ratio of iodine excess only in adequate iodine intake status subgroup; UIC, not the odds ratio of iodine excess, was higher in patients with PTC than those with BTN in above requirements iodine intake subgroup. A novel insight is offered that high UI in PTC patients was less influenced by regional population iodine intake status. It is indicted that high iodine intake is not a risk factor for PTC and high urinary iodine is just a specific characteristic of the disease.

KW - A meta-analysis

KW - Excessive iodine intake

KW - Papillary thyroid carcinoma

KW - Thyroid cancer

KW - Urinary iodine

UR - http://www.scopus.com/inward/record.url?scp=85069237490&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/urinary-iodine-increased-papillary-thyroid-carcinoma-not-altered-regional-population-iodine-intake-s

U2 - 10.1507/endocrj.EJ18-0532

DO - 10.1507/endocrj.EJ18-0532

M3 - Article

VL - 66

SP - 497

EP - 514

JO - Endocrinologia Japonica

JF - Endocrinologia Japonica

SN - 0918-8959

IS - 6

ER -